Health Minister Rona Ambrose launched a new tool under the Regulatory Transparency and Openness Framework: the Drug and Health Product Inspections Database.
This new searchable online resource was designed to provide ready access to information on inspections of companies that manufacture and sell drug products for the Canadian market. Canadians can search the site for plain-language, timely information on foreign and domestic drug inspections conducted by Health Canada and abroad since 2012.
Ambrose says, “Canadians deserve to know that they can trust the health products they use. While Health Canada has always enforced internationally accepted manufacturing standards to help ensure the medicines we take are safe and of high quality, Canadians can now have a better understanding of exactly how Health Canada does this and how companies are measuring up.”
Drugs made in Canada or abroad must meet standards known as Good Manufacturing Practices, which are internationally accepted and enforced by health product regulators. Health Canada licenses and regularly inspects companies that make, package/label, test, import, distribute and wholesale drugs. The searchable Drug and Health Product Inspections Database brings together key data about drug establishments and inspection results, including detailed report cards from inspections of drug establishments in Canada and abroad.
